Novo Nordisk Aktie
| 42,64EUR | -7,36EUR | -14,72% |
WKN DE: A3EU6F / ISIN: DK0062498333
Diese Analysten bewerten die Novo Nordisk-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Barclays Capital | 360,00DKK | -2,12% | 08:37 | |||
| JP Morgan Chase & Co. | 350,00DKK | -4,84% | 02.02.26 | |||
| UBS AG | 390,00DKK | 6,04% | 02.02.26 | |||
| Jefferies & Company Inc. | 270,00DKK | -26,59% | 23.01.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 415,00DKK | 12,83% | 23.01.26 | |||
| Goldman Sachs Group Inc. | 436,00DKK | 18,54% | 22.01.26 | |||
| Deutsche Bank AG | 475,00DKK | 29,15% | 16.01.26 | |||
| Bernstein Research | 540,00DKK | 46,82% | 07.11.25 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|